Search
Search Results
##search.searchResults.foundPlural##
-
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4947PDF: 1922HTML: 2198 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2085PDF: 801HTML: 726Table1: patient's characteristics: 196Table 2: profile of each patient: 216 -
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY
1451PDF: 900HTML: 5087INSTITUTE PUBLICATION COMMITTEE APPROVAL: 200 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9387PDF: 6249HTML: 88128Fig.1b: 248Fig.1c: 249Fig.2a: 233Fig.2b: 231Fig.4: 254Fig.2c: 225Fig.3: 229Tab.1: 289Tab.2: 264Tab.3: 249Tab.4: 280Fig1a: 240 -
Multiple myeloma diagnosed by CT-guided rib biopsy after a hemodilute bone marrow aspirate, in a patient with a biclonal pattern on serum protein electrophoresis Multiple Myeloma diagnosed with CT-guided rib biopsy
257PDF: 128HTML: 277 -
ASSOCIATION OF BASELINE PLATELET COUNT WITH COMPLETE REMISSION, SEVERE BLEEDING, AND 24-MONTH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY
112PDF: 84Suppl. Files: 18Html: 17Html Suppl. Files: 18 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3389PDF: 1543HTML: 5972Fig1-Ag-Pil: 280Ag-Pil Fig.2: 278 -
RECENT ADVANCES IN THE 5Q- SYNDROME
3025PDF: 1917HTML: 3824Pellagatti Fig 1: 262Pellagatti Fig. 2: 249 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
5147PDF: 1366HTML: 1938Untitled: 226Untitled: 210 -
Pathologic splenic rupture in a patient with follicular lymphoma
1494PDF: 605HTML: 1225rupture: 216 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3390PDF: 1775HTML: 1172 -
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
2043PDF: 1180HTML: 1935Lung computed tomography CT scan image: 234 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1694PDF: 1122HTML: 491 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
592PDF: 292HTML: 145 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4080PDF: 1114HTML: 3903Untitled: 198Cneo. Fig.1: 139Untitled: 131Untitled: 156Untitled: 167 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4649PDF: 1803HTML: 1284 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1744PDF: 679HTML: 360 -
Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
1546PDF: 763HTML: 4600Figure 1: Chest radiograph: 254Figure 2: Flow cytometer analysis of pleural fluid: 231 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
1219PDF: 702HTML: 483 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1363PDF: 936HTML: 1203Coverletter: 258 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1843PDF: 1247HTML: 353 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1391PDF: 1110HTML: 441 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4168PDF: 1603HTML: 9313Untitled: 322Untitled: 225Untitled: 206Untitled: 206Untitled: 222Untitled: 373 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
235PDF: 723HTML: 70







